# FDA 483 - Matthew A. Cunningham, M.D. - April 18, 2025

Source: https://www.globalkeysolutions.net/records/483/matthew-a-cunningham-md/fd942fb8-e69a-492e-bb2f-e241af692bb1

> FDA 483 for Matthew A. Cunningham, M.D. on April 18, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Matthew A. Cunningham, M.D.
- Inspection Date: 2025-04-18
- Product Type: drugs
- Office Name: Florida District Office
- Summary: An FDA inspection of Florida Retina Institute, a clinical investigator in Orlando, FL, revealed significant deficiencies in the conduct of a clinical investigation. Observations included failures to follow the investigational plan, improper documentation of informed consent, and inadequate maintenance of case histories. These issues indicate a lack of adherence to regulatory requirements for clinical trials.

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/emily-c-caldwell/101868aa-0586-4d37-8bc6-194f43d66cb7)

Company: https://www.globalkeysolutions.net/companies/matthew-a-cunningham-md/2563c100-1a1c-4899-989d-db02949c3376

Office: https://www.globalkeysolutions.net/offices/florida-district-office/95b2a118-0b78-46e0-a54c-982bd7ce51c9